Q03146
Gene name |
Ddr1 (Cak, Eddr1, Mpk6) |
Protein name |
Epithelial discoidin domain-containing receptor 1 |
Names |
Epithelial discoidin domain receptor 1 , EC 2.7.10.1 , CD167 antigen-like family member A , Cell adhesion kinase , Discoidin receptor tyrosine kinase , Protein-tyrosine kinase MPK-6 , Tyrosine kinase DDR , Tyrosine-protein kinase CAK , CD antigen CD167a |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:12305 |
EC number |
2.7.10.1: Protein-tyrosine kinases |
Protein Class |
|

Descriptions
Autoinhibitory domains (AIDs)
Target domain |
608-903 (Protein kinase domain) |
Relief mechanism |
PTM |
Assay |
|
Accessory elements
No accessory elements
References
- Yeon JH et al. (2016) "Systems-wide Identification of cis-Regulatory Elements in Proteins", Cell systems, 2, 89-100
- Sammon D et al. (2020) "Two-step release of kinase autoinhibition in discoidin domain receptor 1", Proceedings of the National Academy of Sciences of the United States of America, 117, 22051-22060
- Fu HL et al. (2014) "Glycosylation at Asn211 regulates the activation state of the discoidin domain receptor 1 (DDR1)", The Journal of biological chemistry, 289, 9275-87
Autoinhibited structure

Activated structure

1 structures for Q03146
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
AF-Q03146-F1 | Predicted | AlphaFoldDB |
28 variants for Q03146
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
rs3389420336 | 27 | F>S | No | EVA | |
rs3389460633 | 35 | A>G | No | EVA | |
rs3389460706 | 76 | P>H | No | EVA | |
rs3389455441 | 98 | V>E | No | EVA | |
rs3389439837 | 109 | G>W | No | EVA | |
rs3389466192 | 131 | M>V | No | EVA | |
rs3389460438 | 137 | W>L | No | EVA | |
rs3407614649 | 174 | V>I | No | EVA | |
rs3389453705 | 194 | S>L | No | EVA | |
rs3407540098 | 292 | M>I | No | EVA | |
rs3389455373 | 298 | R>L | No | EVA | |
rs3389452303 | 352 | F>I | No | EVA | |
rs3407614661 | 355 | A>T | No | EVA | |
rs3407018854 | 355 | A>V | No | EVA | |
rs3406630009 | 383 | W>R | No | EVA | |
rs3407540105 | 484 | E>G | No | EVA | |
rs3407614664 | 491 | P>L | No | EVA | |
rs3389453778 | 498 | V>L | No | EVA | |
rs3389452273 | 521 | P>S | No | EVA | |
rs3389470497 | 708 | N>D | No | EVA | |
rs3389439882 | 719 | K>M | No | EVA | |
rs3389460628 | 721 | T>I | No | EVA | |
rs3389371605 | 805 | I>T | No | EVA | |
rs3389371602 | 830 | T>N | No | EVA | |
rs3389453684 | 853 | E>K | No | EVA | |
rs3389439874 | 855 | A>V | No | EVA | |
rs3389459826 | 866 | V>I | No | EVA | |
rs3389420334 | 868 | L>F | No | EVA |
No associated diseases with Q03146
10 regional properties for Q03146
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | Protein kinase domain | 137 - 405 | IPR000719 |
domain | Serine-threonine/tyrosine-protein kinase, catalytic domain | 213 - 226 | IPR001245-1 |
domain | Serine-threonine/tyrosine-protein kinase, catalytic domain | 251 - 269 | IPR001245-2 |
domain | Serine-threonine/tyrosine-protein kinase, catalytic domain | 304 - 314 | IPR001245-3 |
domain | Serine-threonine/tyrosine-protein kinase, catalytic domain | 323 - 345 | IPR001245-4 |
domain | Serine-threonine/tyrosine-protein kinase, catalytic domain | 367 - 389 | IPR001245-5 |
domain | SH3 domain | 45 - 109 | IPR001452 |
active_site | Serine/threonine-protein kinase, active site | 257 - 269 | IPR008271 |
binding_site | Protein kinase, ATP binding site | 143 - 164 | IPR017441 |
domain | MLK1-3, SH3 domain | 49 - 106 | IPR035779 |
Functions
Description | ||
---|---|---|
EC Number | 2.7.10.1 | Protein-tyrosine kinases |
Subcellular Localization |
|
|
PANTHER Family | ||
PANTHER Subfamily | ||
PANTHER Protein Class | ||
PANTHER Pathway Category | No pathway information available |
4 GO annotations of cellular component
Name | Definition |
---|---|
basolateral plasma membrane | The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis. |
brush border | The dense covering of microvilli on the apical surface of an epithelial cell in tissues such as the intestine, kidney, and choroid plexus; the microvilli aid absorption by increasing the surface area of the cell. |
plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
receptor complex | Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. |
4 GO annotations of molecular function
Name | Definition |
---|---|
ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
collagen binding | Binding to collagen, a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. Collagen is highly enriched in glycine (some regions are 33% glycine) and proline, occurring predominantly as 3-hydroxyproline (about 20%). |
metal ion binding | Binding to a metal ion. |
protein tyrosine kinase collagen receptor activity | Combining with collagen and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction |
18 GO annotations of biological process
Name | Definition |
---|---|
axon development | The progression of an axon over time. Covers axonogenesis (de novo generation of an axon) and axon regeneration (regrowth), as well as processes pertaining to the progression of the axon over time (fasciculation and defasciculation). |
branching involved in mammary gland duct morphogenesis | The process in which the branching structure of the mammary gland duct is generated and organized. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk. |
cell population proliferation | The multiplication or reproduction of cells, resulting in the expansion of a cell population. |
collagen-activated tyrosine kinase receptor signaling pathway | The series of molecular signals initiated by collagen binding to its receptor on the surface of a target cell where the receptor possesses tyrosine kinase activity, and ending with the regulation of a downstream cellular process, e.g. transcription. |
ear development | The process whose specific outcome is the progression of the ear over time, from its formation to the mature structure. The ear is the sense organ in vertebrates that is specialized for the detection of sound, and the maintenance of balance. Includes the outer ear and middle ear, which collect and transmit sound waves; and the inner ear, which contains the organs of balance and (except in fish) hearing. Also includes the pinna, the visible part of the outer ear, present in some mammals. |
embryo implantation | Attachment of the blastocyst to the uterine lining. |
lactation | The regulated release of milk from the mammary glands and the period of time that a mother lactates to feed her young. |
mammary gland alveolus development | The progression of the mammary gland alveolus over time, from its formation to its mature state. The mammary gland alveolus is a sac-like structure that is found in the mature gland. |
negative regulation of cell population proliferation | Any process that stops, prevents or reduces the rate or extent of cell proliferation. |
neuron projection extension | Long distance growth of a single neuron projection involved in cellular development. A neuron projection is a prolongation or process extending from a nerve cell, e.g. an axon or dendrite. |
peptidyl-tyrosine autophosphorylation | The phosphorylation by a protein of one or more of its own tyrosine amino acid residues, or a tyrosine residue on an identical protein. |
positive regulation of neuron projection development | Any process that increases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites). |
regulation of cell growth | Any process that modulates the frequency, rate, extent or direction of cell growth. |
regulation of cell-matrix adhesion | Any process that modulates the frequency, rate or extent of attachment of a cell to the extracellular matrix. |
regulation of extracellular matrix disassembly | Any process that modulates the rate, frequency or extent of extracellular matrix disassembly. Extracellular matrix disassembly is a process that results in the breakdown of the extracellular matrix. |
smooth muscle cell migration | The orderly movement of a smooth muscle cell from one site to another, often during the development of a multicellular organism. |
smooth muscle cell-matrix adhesion | The binding of a smooth muscle cell to the extracellular matrix via adhesion molecules. |
wound healing, spreading of cells | The migration of a cell along or through a wound gap that contributes to the reestablishment of a continuous surface. |
47 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
Q5F3X2 | DDR1 | receptor protein-tyrosine kinase | Gallus gallus (Chicken) | SS |
Q7YR43 | DDR1 | Epithelial discoidin domain-containing receptor 1 | Pan troglodytes (Chimpanzee) | SS |
Q16832 | DDR2 | Discoidin domain-containing receptor 2 | Homo sapiens (Human) | SS |
Q08345 | DDR1 | Epithelial discoidin domain-containing receptor 1 | Homo sapiens (Human) | EV |
P35546 | Ret | Proto-oncogene tyrosine-protein kinase receptor Ret | Mus musculus (Mouse) | SS |
Q61006 | Musk | Muscle, skeletal receptor tyrosine-protein kinase | Mus musculus (Mouse) | SS |
Q9Z138 | Ror2 | Tyrosine-protein kinase transmembrane receptor ROR2 | Mus musculus (Mouse) | SS |
Q9Z139 | Ror1 | Inactive tyrosine-protein kinase transmembrane receptor ROR1 | Mus musculus (Mouse) | PR |
Q62371 | Ddr2 | Discoidin domain-containing receptor 2 | Mus musculus (Mouse) | SS |
P15209 | Ntrk2 | BDNF/NT-3 growth factors receptor | Mus musculus (Mouse) | SS |
Q3UFB7 | Ntrk1 | High affinity nerve growth factor receptor | Mus musculus (Mouse) | SS |
Q6VNS1 | Ntrk3 | NT-3 growth factor receptor | Mus musculus (Mouse) | SS |
P35917 | Flt4 | Vascular endothelial growth factor receptor 3 | Mus musculus (Mouse) | SS |
P35969 | Flt1 | Vascular endothelial growth factor receptor 1 | Mus musculus (Mouse) | SS |
P35918 | Kdr | Vascular endothelial growth factor receptor 2 | Mus musculus (Mouse) | PR |
Q03145 | Epha2 | Ephrin type-A receptor 2 | Mus musculus (Mouse) | PR |
Q60750 | Epha1 | Ephrin type-A receptor 1 | Mus musculus (Mouse) | SS |
P54761 | Ephb4 | Ephrin type-B receptor 4 | Mus musculus (Mouse) | PR |
Q60629 | Epha5 | Ephrin type-A receptor 5 | Mus musculus (Mouse) | SS |
P97793 | Alk | ALK tyrosine kinase receptor | Mus musculus (Mouse) | SS |
Q9WTL4 | Insrr | Insulin receptor-related protein | Mus musculus (Mouse) | SS |
Q60751 | Igf1r | Insulin-like growth factor 1 receptor | Mus musculus (Mouse) | SS |
P15208 | Insr | Insulin receptor | Mus musculus (Mouse) | SS |
P16092 | Fgfr1 | Fibroblast growth factor receptor 1 | Mus musculus (Mouse) | SS |
P21803 | Fgfr2 | Fibroblast growth factor receptor 2 | Mus musculus (Mouse) | SS |
Q03142 | Fgfr4 | Fibroblast growth factor receptor 4 | Mus musculus (Mouse) | PR |
Q60805 | Mertk | Tyrosine-protein kinase Mer | Mus musculus (Mouse) | SS |
Q62190 | Mst1r | Macrophage-stimulating protein receptor | Mus musculus (Mouse) | SS |
Q00993 | Axl | Tyrosine-protein kinase receptor UFO | Mus musculus (Mouse) | PR |
P55144 | Tyro3 | Tyrosine-protein kinase receptor TYRO3 | Mus musculus (Mouse) | SS |
P70424 | Erbb2 | Receptor tyrosine-protein kinase erbB-2 | Mus musculus (Mouse) | SS |
Q61527 | Erbb4 | Receptor tyrosine-protein kinase erbB-4 | Mus musculus (Mouse) | SS |
Q61526 | Erbb3 | Receptor tyrosine-protein kinase erbB-3 | Mus musculus (Mouse) | SS |
Q01279 | Egfr | Epidermal growth factor receptor | Mus musculus (Mouse) | SS |
Q01887 | Ryk | Tyrosine-protein kinase RYK | Mus musculus (Mouse) | PR |
Q02858 | Tek | Angiopoietin-1 receptor | Mus musculus (Mouse) | SS |
Q06806 | Tie1 | Tyrosine-protein kinase receptor Tie-1 | Mus musculus (Mouse) | SS |
P05532 | Kit | Mast/stem cell growth factor receptor Kit | Mus musculus (Mouse) | PR |
P05622 | Pdgfrb | Platelet-derived growth factor receptor beta | Mus musculus (Mouse) | SS |
P09581 | Csf1r | Macrophage colony-stimulating factor 1 receptor | Mus musculus (Mouse) | SS |
P26618 | Pdgfra | Platelet-derived growth factor receptor alpha | Mus musculus (Mouse) | SS |
Q00342 | Flt3 | Receptor-type tyrosine-protein kinase FLT3 | Mus musculus (Mouse) | SS |
Q61851 | Fgfr3 | Fibroblast growth factor receptor 3 | Mus musculus (Mouse) | PR |
P16056 | Met | Hepatocyte growth factor receptor | Mus musculus (Mouse) | PR |
Q63474 | Ddr1 | Epithelial discoidin domain-containing receptor 1 | Rattus norvegicus (Rat) | SS |
Q95ZV7 | ddr-2 | Discoidin domain-containing receptor tyrosine kinase B | Caenorhabditis elegans | PR |
E7F3X9 | ddr1 | receptor protein-tyrosine kinase | Danio rerio (Zebrafish) (Brachydanio rerio) | SS |
10 | 20 | 30 | 40 | 50 | 60 |
MGTGTLSSLL | LLLLLVTIGD | ADMKGHFDPA | KCRYALGMQD | RTIPDSDISV | SSSWSDSTAA |
70 | 80 | 90 | 100 | 110 | 120 |
RHSRLESSDG | DGAWCPAGPV | FPKEEEYLQV | DLRRLHLVAL | VGTQGRHAGG | LGKEFSRSYR |
130 | 140 | 150 | 160 | 170 | 180 |
LRYSRDGRRW | MDWKDRWGQE | VISGNEDPGG | VVLKDLGPPM | VARLVRFYPR | ADRVMSVCLR |
190 | 200 | 210 | 220 | 230 | 240 |
VELYGCLWRD | GLLSYTAPVG | QTMQLSEVMV | HLNDSTYDGY | TAGGLQYGGL | GQLADGVVGL |
250 | 260 | 270 | 280 | 290 | 300 |
DDFRQSQELR | VWPGYDYVGW | SNQSFPTGYV | EMEFEFDRLR | TFQTMQVHCN | NMHTLGARLP |
310 | 320 | 330 | 340 | 350 | 360 |
GGVECRFKRG | PAMAWEGEPV | RHALGGSLGD | PRARAISVPL | GGHVGRFLQC | RFLFAGPWLL |
370 | 380 | 390 | 400 | 410 | 420 |
FSEISFISDV | VNDSSDTFPP | APWWPPGPPP | TNFSSLELEP | RGQQPVAKAE | GSPTAILIGC |
430 | 440 | 450 | 460 | 470 | 480 |
LVAIILLLLL | IIALMLWRLH | WRRLLSKAER | RVLEEELTVH | LSVPGDTILI | NNRPGPREPP |
490 | 500 | 510 | 520 | 530 | 540 |
PYQEPRPRGT | PPHSAPCVPN | GSALLLSNPA | YRLLLATYAR | PPRGPGPPTP | AWAKPTNTQA |
550 | 560 | 570 | 580 | 590 | 600 |
CSGDYMEPEK | PGAPLLPPPP | QNSVPHYAEA | DIVTLQGVTG | GNTYAVPALP | PGAVGDGPPR |
610 | 620 | 630 | 640 | 650 | 660 |
VDFPRSRLRF | KEKLGEGQFG | EVHLCEVEDP | QDLVSSDFPI | SVHKGHPLLV | AVKILRPDAT |
670 | 680 | 690 | 700 | 710 | 720 |
KNARNDFLKE | VKIMSRLKDP | NIIRLLGVCV | QDDPLCMITD | YMENGDLNQF | LSARQLENKA |
730 | 740 | 750 | 760 | 770 | 780 |
TQGLSGDTES | DQGPTISYPM | LLHVGAQIAS | GMRYLATLNF | VHRDLATRNC | LVGENFTIKI |
790 | 800 | 810 | 820 | 830 | 840 |
ADFGMSRNLY | AGDYYRVQGR | AVLPIRWMAW | ECILMGKFTT | ASDVWAFGVT | LWEVLMLCRS |
850 | 860 | 870 | 880 | 890 | 900 |
QPFGQLTDEQ | VIENAGEFFR | DQGRQVYLSR | PPACPQTLYE | LMLRCWSREP | EQRPPFAQLH |
910 | |||||
RFLADDALNT | V |